Skip to main content
OpenTrials
Completed

NCT Number: NCT03449550

Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea in Children (DINISAS)

To assess the diagnostic validity and cost-effectiveness of a home respiratory polygraphy (HRP) performed at home compared with the standard polysomnography (PSG) in children with clinically suspected Obstructive Sleep Apnea (OSA).

Completed

Looking for future studies?

Notify Me

Key information

Age range

2 year–14 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Universitario Alava

Vitoria-Gasteiz, Alava, 01009, Spain

About this study

AIMS: To assess the diagnostic validity and cost-effectiveness of a home respiratory polygraphy (HRP) performed at home compared with the standard polysomnography (PSG) in children with clinically suspected Obstructive Sleep Apnea (OSA).

METHODOLOGY: DESIGN: Randomized, prospective, multicenter, double blind and crossover trial. The study will include 320 children, both sexes, with clinical suspicion of obstructive sleep apnea (OSA). MEASUREMENTS: To all patients with clinical suspected OSA and referred to the sleep units, the following questionnaires and measurements will be performed: a) clinic history; b) Anthropometric variables: weight, height, body mass index, neck circumference and percentile; c) Chervin questionnaire, quality of life and clinical questionnaires and comorbidity; d) PSG in the sleep laboratory; e) HRP at home; f) Quantitative unbiased proteinic urine analysis and g) Cost-effectiveness variables.

ANALYSIS: Data from HRP and from full PSG will be compared as follows: 1) Agreement of results according to the different apnea-hypopnea index by using the ROC curves; 2) The concordance of the diagnosis and treatment decisions when using clinical findings and data from PSG or HRP at home, 3) All data will be analyzed independently by participating hospitals according the Cohen Kappa method, 4) A diagnosis paradigm based on proteinic defined variables and 5) A cost-effectiveness analysis of the different diagnostic and therapeutic procedures will be performed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children between 2 and 14 years of age of both sexes consecutively assessed for clinical suspicion of OSA, defined as: snoring children with observed respiratory and / or apnea pauses and / or ventilatory effort during observed sleep, and who were asked for a sleep test
  • Written informed consent signed.

Exclusion criteria

  • Place of residence more than 100 km from the hospital
  • Psychophysical incapacity to perform the study at home
  • Severe, unstable or exacerbated cardio-vascular, cerebro-vascular or respiratory disease, that makes it impossible to carry out adequate studies
  • Children with chronic insomnia and / or depressive syndrome
  • Children with malformative syndromes, Down Syndrome and neuromuscular diseases
  • Complete or near complete nasal obstruction that prevents obtaining a quality signal with the HRP
  • History of surgery and / or previous Positive continuous pressure (CPAP) for OSA

Treatment and study plan

Home Respiratory Polygraphy (HRP)

Other

Randomizing to start with home respiratory polygraphy

Other names: Validity

Standard Polysomnography (PSG)

Other

Randomizing to start with Standard Polysomnography (PSG)

Other names: Validity

Primary outcomes

  1. Diagnostic validity of a Home Respiratory Polygraphy (HRP)

    Time frame: baseline

    To establish the diagnostic validity of home respiratory polygraphy (HRP) compared with the findings obtained with polysomnography (PSG) in the sleep laboratory in children with suspected Obstructive Sleep Apnea (OSA), based on the results of Apnea-hypopnea Index (AHI)

Secondary outcomes

  1. Cost effectiveness analysis

    Time frame: baseline

    Cost-efficacy evaluation: the analysis will be made in both arms based on intention to treat. Only direct costs will be analyzed: the cost of the use of polysomnography and home respiratory polygraphy (Staff and consumable material).

  2. Validation of the therapeutic decision

    Time frame: 6 month

    Analyze the concordance in the therapeutic decision using clinical findings and the results of Apnea-Hypopnea Index (AHI) from standard polysomnography (PSG) compared with data from home respiratory polygraphy (HRP)

  3. Validity of the determination of a protein sequence in urine in OSA

    Time frame: baseline

    To analyze the validity of the determination of a protein sequence in urine, alone or in combination, to establish the diagnosis of OSA and to evaluate its modification over time after the treatment of OSA

  4. Pediatric Sleep Questionnaire.

    Time frame: baseline and at six month

    Pediatric Sleep Questionnaire designed to screen for sleep problems in children.The scale consists of 22 parent-reported items examining snoring and breathing problems, daytime sleepiness, inattention, hyperactivity, and other signs and symptoms of apnea including obesity and nocturnal enuresis.

    The result is a number, a proportion that ranges from 0.0 to 1.0. Scores >0.33 are considered positive and suggestive of high risk for a pediatric sleep-related breathing disorder

  5. BEARS Sleep screening

    Time frame: baseline and at six month

    BEARS Sleep screening is divided into five major sleep domains (B=Bedtime Issues, E=Excessive Daytime Sleepiness, A=Night Awakenings, R=Regularity and Duration of Sleep, S=Snoring), providing a comprehensive screen for the major sleep disorders affecting children in the 2- to 18-year old range

  6. Quality of life (KINDLR)

    Time frame: baseline and at six month

    The KINDLR is a generic instrument for assessing Health-Related Quality of Life in children and adolescents aged 3 years and older. Consists of 24 Likert-scaled items associated with six dimensions: physical well-being, emotional well-being, self-esteem, family, friends and everyday functioning (school). The response categories cover 3 levels (1=never, 2=sometimes, 3=very often)

  7. Children's sleep habits questionnaire (CSHQ)

    Time frame: baseline and at six month

    Parent-report sleep screening instrument designed for school-aged children.The instrument evaluates the child's sleep based on behavior within eight different subscales: bedtime resistance, sleep-onset delay, sleep duration, sleep anxiety, night wakings, parasomnias, sleep-disordered breathing, and daytime sleepiness.

  8. Anthropometric variables

    Time frame: baseline and at six month

    Body mass index

  9. Blood pressure

    Time frame: baseline and at six month

    Blood pressure measurements: systolic blood pressure and diastolic blood pressure

Sponsors and collaborators

Lead sponsor

Hospital Universitario Araba

Other

Collaborators

  • Complejo Hospitalario de Caceres
  • Fundación Jimenez Diaz de Madrid
  • Hospital Clínico Universitario de Valladolid
  • Hospital Universitario 12 de Octubre
  • Hospital Universitario La Paz
  • Hospital Universitario Marqués de Valdecilla
  • Hospital Universitario de Burgos
  • Hospital Vall d'Hebron
  • Hospital de Basurto
  • Instituto de Salud Carlos III
  • ResMed
  • University of Chicago
  • University of Guadalajara

Registry information

Official study title

Validity and Cost-effectiveness Analysis of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea in Children (DINISAS)

Acronym: DINISAS

Important dates

Study start
2015
Primary completion
2019
Study completion
2020
First posted
Feb 28, 2018
Registry last updated
Sep 9, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.